| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |